Notably, it has been amply documented that therapeutic administration of IFN-α can induce depression, leading Wichers et al.43 to propose that IDO1 induction (and consequent neurotoxicity) was the principal pathophysiological mechanism. The gene discussed is IFNA1; the disease is major depressive disorder.